ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to slash leukemia relapse after bone marrow transplant
Disease control Recruiting nowThis study tests whether adding two drugs, ruxolitinib and decitabine, to the standard chemotherapy given before a stem cell transplant can lower the chance of leukemia returning in high-risk patients. About 200 adults and teens with acute myeloid leukemia in first remission will…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New study aims to spot lung trouble before it starts in transplant patients
Knowledge-focused Recruiting nowThis study looks for better ways to detect lung inflammation and infections early in people who have received a stem cell transplant from a donor. About 40 participants aged 5 to 70 will get regular lung scans, breathing tests, blood draws, and a procedure where a tube collects f…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Massive study aims to beat deadly fungus in transplant patients
Knowledge-focused Recruiting nowThis study tracks 6000 stem cell transplant patients over 5 years to understand serious fungal infections. Researchers will collect data on diagnosis, treatment, and survival to create better prevention and care guidelines. The goal is to improve long-term outcomes for transplant…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC